Mendus to participate in upcoming industry conferences

Press release

Stockholm, Sweden, June 3, 2024
 

Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, announces that it will participate in the following upcoming industry conferences in June:

BIO International Convention
San Diego, USA, June 3-6, 2024
Mendus Business Development will attend for industry meetings.
BIO International Convention | June 3-6, 2024 | San Diego

European Hematology Association conference 2024
Madrid, Spain, June 13-16, 2024
Mendus will present data from the ADVANCE II Phase 2 trial in acute myeloid leukemia at the European Hematology Association conference (EHA), the leading European hematology conference. Abstracts are available on the conference website.
Events | EHA Library by European Hematology Association (EHA) (ehaweb.org)

ESMO Gynaecological Cancers Congress 2024
Florence, Italy, June 20-22, 2024
Mendus will present data from the ALISON Phase 1 trial in ovarian cancer at the ESMO Gynaecological Cancers Congress. Abstracts will be published on the conference website on June 17.
ESMO Gynaecological Cancers Congress 2024

Datum 2024-06-03, kl 08:00
Källa MFN
Investera som eToros bästa investerare! Med eToros CopyTrader™, kan du automatiskt kopiera andra investerares beslut. Hitta investerare som du tror på och kopiera deras investeringar i realtid. Inga extra avgifter tas ut för funktionen.
Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.